Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Kaiser, Petra
DOB:	04-JUL-1993 (Age: 32)
Gender:	female
Address:	Brandenburgische Strasse 5 67251 Freinsheim (Germany)
ID:	5717-751471-8

Report
Date:	13-JUL-2025

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
Praxis Steger Untere Hauptstraße 63 67551 Worms (Germany)

Specimen
Collected:	12-JUL-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	12 Jul 2025	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.8 H	4.8 - 5.7	%
Glucose [Mass/volume] in Blood	77.5	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	14.3	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.0	0.6 - 1.2	mg/dL
Calcium [Mass/volume] in Blood	8.9	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	137.4	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.2	3.5 - 5	mmol/L
Chloride [Moles/volume] in Blood	101.6	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	25.4	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	171.3	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	106.5	35 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	96.1	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	53.9	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	1.8	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c, indicating impaired glucose metabolism (prediabetes/early diabetes), though current glucose is normal. Renal function (creatinine, microalbumin/creatinine) has improved over time, now within normal limits. Lipid profile is favorable. Electrolytes and other parameters are unremarkable. Recommend continued monitoring of glycemic control and renal function, and clinical correlation for diabetes risk and management.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated HbA1c, indicating impaired glucose metabolism (prediabetes/early diabetes), though current glucose is normal. Renal function (creatinine, microalbumin/creatinine) has improved over time, now within normal limits. Lipid profile is favorable. Electrolytes and other parameters are unremarkable. Recommend continued monitoring of glycemic control and renal function, and clinical correlation for diabetes risk and management.